Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Discover effective ways to use your points for travel. Maximize your rewards and create unforgettable travel experiences.
22,746 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A single insider sale coincided with a sharp move lower in Sprinklr’s shares, prompting questions about signal versus...
NVIDIA remains dominant in AI hardware, but a software-first AI stock is delivering bigger gains. Learn why investors...
As headlines shout about dwindling oil, some stocks stand out no matter the price: upstream producers ride price cycl...
Investors chasing solid returns in AI don’t have to chase sky-high premiums. This guide highlights three great value ...
Discover how to read arbe (arbe) 2025 earnings from the Q4 transcript, uncover management priorities, and turn insigh...
When a blue-chip name like Microsoft moves, it can shake nerves and portfolios. This guide explains why microsoft sto...
Could canopy growth stock realistically quadruple from here? This deep-dive walks through the bull case, the risks, a...
In crypto analytics, cost and speed matter as much as accuracy. A perplexity fine-tuned chinese model offers a breakt...
A sizable Hershey share sale by the milton hershey school trust sparks questions about insider activity and stock imp...
A single calendar day could push the market in surprising directions. This article explains why Feb 26 matters for AI...
Palantir’s AI-enabled analytics engine has fueled growth, but the stock faces multiple headwinds. This article lays o...